Viscosupplementation Market Analysis

Application (Knee Osteoarthritis, Shoulder Osteoarthritis, Hip Osteoarthritis)

The global viscosupplementation market is segmented and analyzed for demand and supply by application into knee osteoarthritis, shoulder osteoarthritis, hip osteoarthritis, and others. Out of these types of applications, the knee osteoarthritis segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the notably growing prevalence of knee osteoarthritis in people with unhealthy lifestyles across the globe and a rising geriatric population that are prone to knee problems. It was observed that, in 2019, knee osteoarthritis accounted for approximately 60.6% of all prevalent cases globally. Knee osteoarthritis is associated with cartilage breakdown which makes bones rub together. It can be caused by obesity, injuries, and infections. Sports injuries cause a notable number of knee osteoarthritis and other reason such as infections generally cause these issues in people aged above 45. For instance, it was observed that around 3 million children receive sports injuries every year across the globe.

Product (Single Injection, Three Injections, Five Injections)

The global viscosupplementation market is also segmented and analyzed for demand and supply by-products into single injection, three injection, and five injections. Amongst these three segments, the five injections segment is expected to garner a significant share. The segment is expected to grow since it is observed that patients require 5 injections per week to relieve the pain in the joints. Viscosupplementation treatment is reserved until no other option can relieve the pain in joints. The series of injections are repeated every 6 months. As of 2021, the viscosupplementation treatment expenditure was evaluated to be approximately USD 250 million globally. Furthermore, three injection segment is also projected to witness noteworthy growth over the forecast period. Every knee therapy requires 3 weekly injections of hylan G-F 20. For instance, gel and cortisone injections are some of the types of VS therapy injections.

Our in-depth analysis of the global viscosupplementation market includes the following segments: